The spectrum of cold urticaria

⁠In this episode, Prof. Torsten Zuberbier calls up Dr. Hanna Bonnekoh, dermatologist and researcher at Charité Berlin, to dive into the complexities of cold-induced urticaria—particularly rare and familial forms that challenge current diagnostics and treatments. ⁠


They discuss:

🔹 What makes wind-induced cold urticaria so difficult to diagnose?

🔹 How can physicians distinguish between histamine- and IL-1-mediated disease?

🔹 What role do biologics like omalizumab and dupilumab play in treatment?

🔹 Why are IL-1 blockers crucial in autoinflammatory syndromes like Muckle-Wells-syndrome?


Dr. Bonnekoh shares her clinical perspective on diagnostic tools like the TempTest, the pathophysiology behind cold urticaria variants, and how novel therapies like anti-CKIT antibodies are shaping the future of care. She also emphasizes the importance of family history, wheal morphology, and systemic symptoms when evaluating patients with atypical urticaria.

Join us for a deep dive into cold urticaria phenotypes, treatment strategies, and the call for more research and global registry data to support patients worldwide.


Key Learnings from the Episode

Cold urticaria includes rare phenotypes, such as wind-induced and familial forms, often undetectable by standard tests.

The TempTest is useful for threshold diagnosis, but not all cold urticaria types respond.

Histamine-mediated urticaria may respond to antihistamines or omalizumab, while IL-1-mediated types (e.g., Muckle-Wells) require immunomodulatory therapy.

IL-1 plays a key role in autoinflammation; identifying its overproduction is crucial in diagnosis.

CRP and ESR are easy, accessible lab markers to differentiate urticaria types.

New biologics like anti-CKIT antibodies (e.g., barzolvolimab) are promising in depleting mast cells.

Wheal appearance, duration, and sensations (itch vs. burn) help guide subtype classification.

Cold-induced cholinergic urticaria is an emerging phenotype needing further research.

Global registries like CURE are key to improving care for rare urticaria types.


Chapters

00:00 Introduction to Cold-Induced Problems

03:29 Understanding Atypical Cold Urticaria

06:23 Treatment Options for Cold Urticaria

09:12 Exploring Rare Forms of Cold Urticaria

11:53 The Role of Interleukin-1 in Cold Urticaria

14:40 Differential Diagnosis in Cold Urticaria

17:15 Research and Future Directions in Cold Urticaria


Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.


Feedback form:

ATU: ⁠⁠⁠⁠https://forms.office.com/e/m6a2uEdsUH

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(121)

AI and the Future of Urticaria

AI and the Future of Urticaria

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Hermenio Lima discuss the growing role of artificial intellig...

16 Jun 16min

Urticaria Triggers: Infection Insights

Urticaria Triggers: Infection Insights

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Maia Gotua discuss the role of infections in acute and chroni...

19 Mai 16min

A New Era in Urticaria Treatment

A New Era in Urticaria Treatment

In this episode of “All Things Urticaria” — a podcast from UCARE, the Global Allergy and Asthma Excellence Network — Prof. Torsten Zuberbier and Prof. Ana Giménez-Arnau discuss the newly released inte...

23 Apr 19min

Managing Urticaria in Resource-Limited Settings

Managing Urticaria in Resource-Limited Settings

In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Dr. Emma Kruger from Cape Town, South Africa, about managing urticar...

24 Mar 17min

Drug Survival of Omalizumab

Drug Survival of Omalizumab

In this episode of the Urticaria podcast series, Prof. Torsten Zuberbier speaks with Reineke Soegiharto, PhD candidate and dermatology resident from UMC Utrecht, about the international UCARE study DR...

24 Feb 17min

Visualizing Urticaria Worldwide

Visualizing Urticaria Worldwide

In this episode of the GA²LEN Urticaria Podcast, Professor Torsten Zuberbier is joined by Professor Simon Francis Thomsen from Denmark to introduce an exciting new global initiative within the UCARE n...

28 Jan 19min

A New Era for Urticaria Treatment

A New Era for Urticaria Treatment

In this short, conference-based episode, Professor Torsten Zuberbier, President of Global Allergy and Asthma Excellence Network, speaks with Professor Kiran Godse from Mumbai, India, directly from the...

18 Des 20255min

Measuring What Matters: PROMs in Urticaria Care

Measuring What Matters: PROMs in Urticaria Care

In this episode of the GA²LEN (Global Allergy and Asthma Excellence Network) Podcast on Everything Urticaria, Professor Torsten Zuberbier talks with Dr. Karsten Weller, a leading expert and developer ...

2 Des 202519min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
liberal-halvtime
rekommandert
forskningno
sinnsyn
villmarksliv
smart-forklart
dekodet-2
tomprat-med-gunnar-tjomlid
fjellsportpodden
rss-nysgjerrige-norge
noen-har-snakket-sammen
rss-inn-til-kjernen-med-sunniva-rose
rss-overskuddsliv
rss-paradigmepodden
vett-og-vitenskap-med-gaute-einevoll
rss-rekommandert
rss-bondevennen